Cloning and sequencing of an ovine interleukin-5 cDNA

References

• Azuma C., Tanabe T., Konishi M., Kinashi T., Noma T., Matsuda F., Yaoita Y., Takatsu K., Hammarstroem L., et al. “Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue”. Nucl. Acid. Res. 1986; 14: 9149–9158
   PubMed Web of Science ®Google Scholar
• Campbell H. D., Tucker W. Q.J., Hort Y., Martinson M. E., Mayo G., Clutterbuck E. J., Sanderson C. J., Young I. G. “Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentation factor (inter-leukin 5)”. Proc. Natl. Acad. Sci. USA 1987; 84: 6629–6633
   PubMed Web of Science ®Google Scholar
• Campbell H. D., Sanderson C. J., Wang Y., Hort Y., Martinson M. E., Tucker W. Q., Stellwagen A., Strath M., Young I. G. “Isolation, structure and expression of cDNA and genomic clones for murine eosinophil differentiation factor. Comparison with other eosinophilopoietic lymphokines and identity with interleukin-5”. Eur. Biochem J. 1988; 174: 345–352
   PubMedGoogle Scholar
• Coffman R. L., Seymour B. W.P., Hudak S., Jackson J., Rennick D. “Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice”. Science 1989; 245: 308–310
   PubMed Web of Science ®Google Scholar
• Comelis S., Plaetinck G., Devos R., Vahderheyden J., Tavernier J., Sanderson C. J., Guisez Y., Fiers W. “Detailed analysis of the IL-5-IL-5R-alpha interaction-characterisation of crucial residues on the ligand and the receptor”. Embo J. 1995; 14: 3395–3402
   PubMedGoogle Scholar
• Dent L. A., Strath M., Mellor A. L., Sanderson C. J. “Eosinophilia in transgenic mice expressing interleukin 5”. Exp. J. Med. 1990; 172: 1425–1431
   PubMed Web of Science ®Google Scholar
• Devos R., Plaetinck G., Van-Der-Heyden J., Comelis S., Van-Dekerckhove J., Fiers W., Tavernier J. “Molecular basis of a high affinity murine interleukin-5”. Embo J. 1991a; 10: 2133–2137
   PubMed Web of Science ®Google Scholar
• Devos R., Vandekerckhove J., Rolink A., Plaetinck G., Van-Der-Heyden J., Fiers W., Tavernier J. “Amino acid sequence analysis of a mouse interleukin 5 receptor protein reveals homology with a mouse interleukin 3 receptor protein”. Eur. Immunol J. 1991b; 21: 1315–1318
   PubMedGoogle Scholar
• Graber P., Proudfoot A. E.I., Talabot F., Bernard A., McKinnon M., Banks M., Fattah D., Solari R., Peitsch M. C., Wells T. N.C. “Identification of key charged residues of human interleukin-5 in receptor binding and cellular activation”. Biol J. Chem. 1995; 270: 15762–15769
   Google Scholar
• Jones D. G. “The Eosinophil”. J. Comp. Path. 1993; 108: 317–335
   PubMed Web of Science ®Google Scholar
• Kinashi T., Harada N., Severinson E., Tanabe T., Sideras P., Konishi M., Azuma C., Tominaga A., Bergstedt-Lindqvist S., et al. “Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II”. Nature 1986; 234: 70–72
   Google Scholar
• Koyama N., Harada N., Takahashi T., Mita S., Okamura H., Tominaga A., Takatsu K. “Role of recombinant inter-leukin-1 compared to recombinant T-cell replacing factor/inter-leukin-5 in B-cell differentiation”. Immunology 1988; 63: 277–283
   PubMed Web of Science ®Google Scholar
• Lopez A. F., Vadas A., Woodcock J. M., Milton S. E., Lewis A., Elliott M. J., Gillis D., Ireland R., Olwell E., Park L. S. “Interleukin-5, interIeukin-3 and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface respectors on human eosinophils”. J. Biol. Chem. 1991; 266: 24741–24747
   PubMed Web of Science ®Google Scholar
• McKenzie A. N.J., Ely B., Sanderson C. J. “Mutated interleukin-5 monomers are biologically inactive”. Mol. Immunol. 1991a; 28: 155–158
   PubMed Web of Science ®Google Scholar
• McKenzie A. N.J., Barry S. C., Strath M., Sanderson C. J. “Structure-function analysis of interleukin-5 utilising mouse/human chimeric molecules”. Embo J. 1991b; 10: 1193–1199
   PubMed Web of Science ®Google Scholar
• Milburn M. V., Hassell A. M., Lambert M. H., Jordan S. R., Proudfoot A. E.I., Graber P., Wells T. N.C. “A novel dimer configuration revealed by the crystal structure at 2.4 Angstroms resolution of human interleukin-5”. Nature 1993; 363: 172–176
   PubMed Web of Science ®Google Scholar
• Minamitake Y., Kodama S., Katayama T., Adachi H., Tanaka S., Tsujimoto M. “Structure of recombinant human interleukin 5 produced by Chinese hamster ovary cells”. J. Biochem. 1990; 107: 292–297
   PubMed Web of Science ®Google Scholar
• Mizuta T. R., Tanabe T., Nakakubo H., Noma T., Honjo T. “Molecular cloning and structure of the mouse intereleukin-5 gene”. Growth Factors 1989; 1: 51–57
   Google Scholar
• Murata Y., Takaki S., Migita M., Kikuchi Y., Tominaga A., Takatsu K. “Molecular cloning and expression of the human interleukin 5 receptor”. J. Exp. Med. 1992; 175: 341–351
   PubMed Web of Science ®Google Scholar
• Sanderson C. D., Warren D. J., Strath M. “Identification of a lymphokine that stimulates eosinophil differentation in vitro”. J. Exp. Med. 1985; 162: 60–74
   PubMed Web of Science ®Google Scholar
• Sanderson C. J., Campbell H. D., Young I. G. “Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells”. Immunol. Rev. 1988; 102: 29–50
   PubMed Web of Science ®Google Scholar
• Sonda E., Hitoshi Y., Yamaguchi N., Ishi T., Tominaga A., Araki S., Takatsu K. “Differential Regulation of IgA production by TCF-β and IL-5, TGF-β induces surface IgA-positive cells bearing IL-5 receptor, whereas IL-5 promotes their survival and maturation into IgA-secreting cells”. Cell. Immunol. 1992; 140: 158–172
   PubMedGoogle Scholar
• Stevenson L. M., Jones D. G. “Cross-reactivity amongst recombinant haematopoietic cytokines from different species for sheep bone-marrow eosinophils”. J. Comp. Path. 1994; 111: 99–106
   PubMedGoogle Scholar
• Tavernier J., Devos R., Cornelis S., Tuypens T., Van-Der-Heyden J., Fiers W., Plaetinck G. “A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CS”. Cell 1991; 66: 1175–1184
   PubMed Web of Science ®Google Scholar
• Tavernier J., Tuypens T., Verhee A., Plaetinck G., Devos R., Vanderheyden J., Guisez Y., Oefner C. “Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist”. Proc. Natl. Acad. Sci. USA 1995; 92: 5194–5198
   PubMed Web of Science ®Google Scholar
• Ueberla K., Li W., Qin Z., Richter G., Raabe T., Diamantstein T., Blankenstein T. “The rat interleukin-5 gene: Characterisation and expression by retroviral gene transfer and polymerase chain reaction”. Cytokine 1991; 3: 72–81
   PubMedGoogle Scholar